Myriad Genetics AI Price Prediction

The company is currently unprofitable, as indicated by its negative EPS and resulting negative P/E ratio. This suggests ongoing losses and likely margin pressure, with no clear evidence from the provided data that profitability is imminent. From a fundamentals standpoint, the stock is in a turnaround or distressed phase rather than a stable growth profile.

• Negative EPS of -3.92 implies the company is losing money on a per‑share basis, pointing to weak bottom-line performance.
• A P/E ratio of -0.79 confirms the absence of positive earnings and indicates the market is valuing the stock more on hopes of future improvement than on current profits.
• Without evidence of improving margins or consistent revenue growth in the data provided, the risk profile remains elevated and the financial picture leans clearly bearish.

The stock trading at $3.08 after a 47.5% decline in the last month signals severe negative momentum and likely capitulation by many investors. The price is dramatically below the 200‑day moving average of $20.78, indicating a strong, entrenched downtrend. From a technical standpoint, the setup reflects a high‑risk, falling‑knife profile rather than a stable base.

• A 47.5% drop in one month is an extreme move, typically associated with negative news, guidance cuts, or a sharp deterioration in investor confidence.
• The current price of $3.08 versus a 200‑day moving average of $20.78 shows the stock is deeply below long‑term trend, a classic sign of a strong bearish trend.
• Given the magnitude of the decline and distance from the 200‑day MA, any short‑term oversold bounce (which would be reflected in a low RSI, though not provided) would still occur within a clearly bearish longer‑term technical structure.

Combining unprofitable fundamentals with a severe recent price collapse and a stock trading far below its 200‑day moving average yields an overall bearish view. Alternative data show stability rather than growth acceleration and are not strong enough to counterbalance the negative earnings profile and technical damage. Until there is clear evidence of improving profitability or a durable price base, the risk/reward skews negatively.

• Negative earnings, a deeply negative P/E, and lack of clear improvement in profitability underpin a fundamentally bearish stance.
• The extreme drawdown and large gap below the 200‑day moving average signal a strong downtrend and damaged investor sentiment that is unlikely to reverse quickly without a fundamental catalyst.